FDA Inspection 648501 — Oklahoma Blood Institute East Central
The FDA completed an inspection of Oklahoma Blood Institute East Central on Feb 24, 2010 in Ada, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 24, 2010
- Fiscal Year
- 2010
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ada, OK (United States)